Jaeckel E, Becker T, Manns M P
Abteilung Gastroenterologie, Hepatologie, Endokrinologie, Medizinische Hochschule Hannover.
Internist (Berl). 2004 Nov;45(11):1268-80. doi: 10.1007/s00108-004-1303-7.
Pancreas transplantation is a successful and effective procedure resulting in tight glucose control. Due to the postoperative morbidity and the need for immunosuppression pancreas transplantation should be considered at the time of kidney transplantation. Besides this, pancreas transplantation alone should be considered for patients with unacceptably poor metabolic control and quality of life despite optimal medical treatment. Recently, islet transplantation became a less invasive alternative to pancreas transplantation. Due to the lack of long-term follow-up and due to the need of multiple donor grafts for one recipient, islet transplantation should be performed under experimental settings in experienced centers. New developments in protecting transplanted islets and in the induction of donor-specific tolerance could increase the indication to perform the procedure. Therefore alternative sources of beta-cells have to be identified.
胰腺移植是一种成功且有效的手术,可实现严格的血糖控制。由于术后发病率以及免疫抑制的需求,胰腺移植应在肾移植时予以考虑。除此之外,对于尽管接受了最佳药物治疗但代谢控制和生活质量仍差得难以接受的患者,应考虑单独进行胰腺移植。近来,胰岛移植成为了一种侵入性较小的胰腺移植替代方法。由于缺乏长期随访以及一名受者需要多个供体移植物,胰岛移植应在经验丰富的中心的实验环境下进行。在保护移植胰岛和诱导供体特异性耐受方面的新进展可能会增加该手术的适应症。因此,必须确定β细胞的替代来源。